ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,266.95
      -0.74%
      US Tech 100
      18,198.00
      -0.33%
      Dow Jones
      38,441.54
      -1.06%
      Brent Oil
      83.395
      0.02%
      Bitcoin
      68,013.38
      0.64%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Zosano Pharma Corporation (ZSAN)

      7. Zosano Pharma Corporation (ZSAN) News

      ZSAN

      Zosano Pharma (ZSAN)

      Zosano Pharma Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ZSAN
      DateTimeSourceHeadlineSymbolCompany
      07/19/202211:48AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ZSANZosano Pharma Corporation
      06/07/20227:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZSANZosano Pharma Corporation
      06/07/20227:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZSANZosano Pharma Corporation
      06/02/20228:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
      06/02/20228:00AMGlobeNewswire Inc.Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11NASDAQ:ZSANZosano Pharma Corporation
      05/18/20228:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
      05/13/20224:17PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ZSANZosano Pharma Corporation
      05/13/20224:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
      05/13/20224:00PMGlobeNewswire Inc.Zosano Pharma Reports First Quarter 2022 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
      05/05/20225:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
      04/29/20224:02PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ZSANZosano Pharma Corporation
      04/29/20224:00PMGlobeNewswire Inc.Zosano Pharma Provides Corporate UpdateNASDAQ:ZSANZosano Pharma Corporation
      04/11/20228:00AMGlobeNewswire Inc.Zosano Pharma Announces Reverse Stock Split Effective TodayNASDAQ:ZSANZosano Pharma Corporation
      04/01/20224:22PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ZSANZosano Pharma Corporation
      03/22/20227:46AMTipRanksMaxim Group Thinks Zosano Pharma’s Stock is Going to RecoverNASDAQ:ZSANZosano Pharma Corporation
      03/17/20224:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
      03/17/20224:05PMGlobeNewswire Inc.Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
      02/14/20226:19AMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ZSANZosano Pharma Corporation
      02/11/20225:31PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ZSANZosano Pharma Corporation
      02/09/20225:22PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
      02/09/20225:16PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ZSANZosano Pharma Corporation
      02/08/20229:55PMGlobeNewswire Inc.Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and WarrantsNASDAQ:ZSANZosano Pharma Corporation
      02/08/20224:18PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ZSANZosano Pharma Corporation
      02/08/20224:10PMGlobeNewswire Inc.Zosano Pharma Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:ZSANZosano Pharma Corporation
      01/24/20228:20AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
      01/05/202212:01PMGlobeNewswire Inc.CORRECTION - Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher DoseNASDAQ:ZSANZosano Pharma Corporation
      01/05/20229:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
      01/05/20229:20AMGlobeNewswire Inc.Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher DoseNASDAQ:ZSANZosano Pharma Corporation
      12/13/20214:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
      12/13/20214:30PMGlobeNewswire Inc.Zosano Pharma Announces Changes to Board of Directors; Appoints Cross Functional Business Executive Elaine M. YangNASDAQ:ZSANZosano Pharma Corporation
       Showing the most relevant articles for your search:NASDAQ:ZSAN